Name | Kinase inhibitor-1 |
Synonyms | Tarlox-TKI Kinase inhibitor-1 2-Butenamide, N-[4-[(3-bromo-4-chlorophenyl)amino]pyrido[3,4-d]pyrimidin-6-yl]-4-(dimethylamino)-, (2E)- |
CAS | 2135696-72-7 |
Molecular Formula | C19H18BrClN6O |
Molar Mass | 461.74 |
Density | 1.552±0.06 g/cm3(Predicted) |
Boling Point | 647.4±55.0 °C(Predicted) |
pKa | 9.68±0.43(Predicted) |
Storage Condition | 2-8℃ |
Use | Kinase inhibitor-1 (Compound 5) is a Kinase inhibitor. |
In vitro study | Epidermal Growth Factor Receptor (EGFR, HER1) is an attractive therapeutic target for many cancer types. Tarlox-TKI is a dose-potent EGFR inhibitor. |